US Patent:
20100048577, Feb 25, 2010
Inventors:
Joerg R. Leheste - Rocky Point NY, US
German Torres - Sea-Cliff NY, US
International Classification:
A61K 31/05
A61K 31/496
A61K 31/498
A61K 31/429
US Classification:
514249, 514733, 51425402, 514368
Abstract:
The invention relates to the discovery that resveratrol, and substituted forms of resveratrol, are effective in alleviating benign prostate hyperplasia. Formulations containing the resveratrol or resveratrol derivative, lack omega-3 fatty acids, and also contain no other compounds which activate SIRT1 and PGCα.